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Background
An estimate ofprognosis ofpatients with terminal cancer is
important for everybody involved in the case ofthese
patients. An accurate esfimation allows the appropriate
planiing oftheir medical care and might improve the
patient's quality ofdying. However, a prognostic model for
such patients has not yet been established. In fact, several
studies showed physicians' predictions ofsurvival were
often erroneous and optimistic [1,2].
The purpose ofthis study was to develop prognostication
models for temnal cancer patients using selected data
mining techniques.
Methods
A total of311 patients with terninary ill cancer, who
admitted to the hospice ward at the Japan Baptist Hospital
from 1995 to 2000, were included in this analysis.
Twenty-tree variables including age, gender, blood count
and serum laboratory measurements at the initial hospital
admission were retrospectively collected. For model
validation purposes, the data was split to training set (237
patients) and test set (74 patients).
Three statistical and data mining techniques, i.e., logistic
regression analysis (LR), naive Bayesian (NB) and decision
free induction (T1) were used to develop prognostic models
on the training data. All models were designed to predict
30-day suival after the first admission to the hospice ward.
Classification accuracy (CA), sensitivity, specificity and
area under the receiver operating characteristic curve (AUC)
were calculated to evaluate the accuracy ofeach model.
Results
The numbers of30-day survival were 65.4% (155 patients)
in the tiing data and 58.1% (43)inthetest data,
respectively (P=0.255). LR identified 7 variables;
lymphocyte, platelet, total protein, total bilirubin, AST, urea
nitrogen and Chloride. NB identified 12 variables;
lymphocyte, urea nitrogen, calcium, sodium, total bilinubin,
total protein, eosinocyte, gender, AST, chloride, white blood
cell and platelet. TI identified 4 variables; total bilirubin,
lymphocyte, chloride and eosinocyte. CA, sensitivity,
specificity andAUC ofeach model in the test data are listed
in Table 1.
Table 1 Test Characteistics ofEach Prognostic Model in
the test data
| CA Sensiivi Specificity AUC
LR 73.0 58.1 83.7 74.8
NB 77.0 67.7 83.7 80.6
TI 60.8 45.2 72.1 65.1
Conclusion
Three different data mining techniques independently
identified total bilirubin, fraction oflymphocyte and
electrolytes as impnt predictive factors for terminally ill
cancer patients. Data mining techniques are thus useful tools
in uncovenng important relationships among clinical factors
and patient outcomes within an existing database.
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